Lauren Radford

Dr. Lauren Radford

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 November 2019 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
LRLauren Radford
Lauren Radford
SFSolana Fernandez
Solana Fernandez
RBRebecca Beacham
Rebecca Beacham
RSRetta El Sayed
Retta El Sayed
RFRenata Farkas
Renata Farkas
SLSuzane Lapi
Suzane Lapi
Overexpression of folate receptors (FRs) on different tumor types (e.g., ovarian, lung) make FRs attractive in vivo targets for directed diagnostic/therapeutic agents. Currently, no diagnostic agent suitable for positron emission tomography (PET) has been adopted for clinical FR imaging. In this work, two 55Co-labeled albumin-binding folate derivatives-[55Co]Co-cm10 and [55Co]Co-rf42-with characteristics suitable for PET imaging have been developed and evaluated. High radiochemical yields (≥95%) and in vitro stabilities (≥93%) were achieved for both compounds, and cell assays demonstrated FR-mediated uptake. Both 55Co-labeled folate conjugates demonstrated high tumor uptake of 17% injected activity per gram of tissue (IA/g) at 4 h in biodistribution studies performed in KB tumor-bearing mice. Renal uptake was similar to other albumin-binding folate derivatives, and liver uptake was lower than that of previously reported [64Cu]Cu-rf42. Small animal PET/CT images confirmed the biodistribution results and showed the clear delineation of FR-expressing tumors.

1 April 2017 in Nuclear Medicine and Biology
Verified
Journal Article
Closed access
LRLauren Radford
Lauren Radford
FGFabio Gallazzi
Fabio Gallazzi
LWLisa Watkinson
Lisa Watkinson
TCTerry Carmack
Terry Carmack
ABAshley Berendzen
Ashley Berendzen
HHHeather M. Hennkens
Heather M. Hennkens

1 February 2019 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
LRLauren Radford
Lauren Radford
DPDionysia Papagiannopoulou
Dionysia Papagiannopoulou
FGFabio Gallazzi
Fabio Gallazzi
ABAshley Berendzen
Ashley Berendzen
LWLisa Watkinson
Lisa Watkinson
HHHeather M. Hennkens
Heather M. Hennkens

7 September 2020 in IEEE Transactions on Medical Imaging
Verified
Journal Article
Closed access
FJFloris P. Jansen
Floris P. Jansen
TDTimothy W. Deller
Timothy W. Deller
MFMark D. Fries
Mark D. Fries
MKMohammad Mehdi Khalighi
Mohammad Mehdi Khalighi
SWSharon L. White
Sharon L. White
SLSuzane Lapi
Suzane Lapi
Accurate gain control of PET detectors is a prerequisite for quantitative accuracy. A shift in the 511 keV peak position can lead to errors in scatter correction, degrading quantitation. The PET detectors in a PET/MR scanner are subject to thermal transients due to eddy currents induced during gradient-intensive MRI sequences. Since the gain of silicon photomultiplier-based detectors changes with temperature, good gain control is particularly challenging. In this paper we describe a method that utilizes information from the entire singles spectrum to create a real-time gain control method that maintains gain of PET detectors stable within approximately ±0.5% (±2.5 keV) with varying levels of scatter and in the presence of significant thermal transients. We describe the methods used to combine information about multiple peaks and how this algorithm is implemented in a way that permits real-time processing on a field-programmable gate array. Simulations demonstrate rapid response time and stability. A method (“virtual scatter filter”) is also described that extracts unscattered photopeak events from phantom data and demonstrates the accuracy of the photopeak for various radionuclides that emit energies in addition to the pure 511 keV annihilation peak. Radionuclides 52Mn, 55Co, 64Cu, 89Zr, 90Y, and 124I are included in the study for their various forms of spectral contamination.